TSI Pharmaceuticals expands with acquisition of National ProPack
Sydney, Australia –
Australian contract manufacturing and packaging company, National ProPack, previously owned by National Chemicals Pty. Ltd., has become a wholly owned part of Australian contract manufacturing company TSI Pharmaceuticals, part of the global TSI Group. Specific terms of the deal were not disclosed.
The acquisition includes ProPack’s manufacturing facility in Brisbane providing TSI with expanded capacity to manufacture liquids and creams in topical format for therapeutic and Australian Pesticides and Veterinary Medicines Authority (APVMA) products, as well as industrial applications, in a wide variety of jars, tubes and bottles.
According to Ian Chant, TSI Pharmaceuticals managing director, the acquisition will strengthen TSI Pharmaceuticals product offerings, particularly related to the production of its locally made liquids and creams. Both National ProPack and TSI Pharmaceuticals are backed by the TSI Group, a global researcher, developer and manufacturer of ingredients and finished products with offices in Europe, Japan, China, Australia and the U.S.
As part of the TSI Group, ProPack will have the opportunity to offer customers the benefits of an expanded operation gaining access to worldwide innovation, economic purchasing and the vertical integration of closely controlled raw material manufacturers.
"This acquisition further fortifies TSI’s global supply chain strategy to manufacture in the country that provides our customers with the best quality, delivery performance and value," said Chant.
ProPack owner Robert Bowser said his company was looking forward to providing clients an extended quality product offering made possible by the union of these two organizations.
"TSI is a strong organization which has experience managing product lines similar to ours and will certainly provide opportunities for growth," Bowser said.
TSI Pharmaceuticals (www.tsipharma.com.au), located in Brisbane, Australia, has been operating since 1988. It supplies both TGA standards bulk and packed therapeutic goods to a wide range of customers in Australia and New Zealand. TSI is a premium producer of pharmaceutical, over the counter and supplement grade glucosamine and chondroitin, working in more than eight countries. It became part of the global TSI Group in 2011. The TSI Group operates four cGMP manufacturing facilities, customer service offices worldwide and a 40-acre fully integrated manufacturing, research and quality assurance campus.
National ProPack (www.nationalpropack.com.au) is a contract manufacturing and packaging company offering product development, manufacturing, filling, and packaging for the pharmaceutical, veterinary, cosmetic and consumer goods area. National ProPack GMP licensed manufacturing facility adheres to the strictest standards of quality assurance.